Ralliant Corporation (RAL) to Issue Quarterly Dividend of $0.05 on June 23rd

Ralliant Corporation (NYSE:RAL) declared a quarterly dividend on Thursday, May 7th. Stockholders of record on Monday, June 8th will be paid a dividend of 0.05 per share on Tuesday, June 23rd. This represents a c) dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Monday, June 8th.

Ralliant Trading Down 3.6%

Shares of NYSE:RAL opened at $60.18 on Friday. Ralliant has a 1 year low of $37.27 and a 1 year high of $63.31. The firm has a market capitalization of $6.74 billion and a price-to-earnings ratio of -5.50. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.61 and a quick ratio of 1.05. The business’s 50 day moving average price is $50.75 and its 200-day moving average price is $49.20.

Ralliant (NYSE:RAL) last announced its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The firm had revenue of $534.60 million for the quarter. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, equities research analysts forecast that Ralliant will post 2.64 earnings per share for the current fiscal year.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.